LINVESTA LINAGLIPTIN 5MG TABLETS 30’S

Linvesta (Linagliptin) 5mg tablets are a prescription medication primarily used for the management of type 2 diabetes mellitus. This drug belongs to a class of medications known as DPP-4 inhibitors, which work by increasing the levels of incretin hormones in the body. These hormones help to regulate blood sugar levels by stimulating insulin release and decreasing glucagon secretion, especially after meals.

Linvesta is often prescribed to improve glycemic control in adults with type 2 diabetes, either as a monotherapy or in combination with other antidiabetic agents. It is particularly beneficial for patients who are overweight or have cardiovascular concerns, as it has a neutral effect on weight and a favorable safety profile. Additionally, Linvesta is convenient as it is taken once daily, without the need for dose adjustments based on renal function. This makes it a popular choice among healthcare providers in Kenya for managing diabetes effectively.